Business Context and Reporting Period
This Form 6-K is filed by Golden Sun Health Technology Group Limited, a Cayman Islands exempted company, for the month of August 2025. The report addresses the company's compliance status with Nasdaq Capital Market listing requirements following a significant capital restructuring event.
Key Financial Metrics and Capital Structure
- Debt and Equity Reclassification: The company reclassified approximately $9.4 million (the carrying value of a Convertible Note and Warrant as of March 31, 2025) from liabilities to total equity.
- Share Issuance: On August 22, 2025, the company issued an aggregate of 6,747,926 Class A Ordinary Shares to investors upon the full exercise of warrants and conversion of the note.
- Outstanding Instruments: The Convertible Note (originally $5,000,000 principal) and the associated Warrant are no longer outstanding.
- Revenue and Profit: The filing text does not provide a clear value for revenue, profit, cash flow, or operating margins for this period.
Material Changes Versus Prior Period
The primary material change is the elimination of the $5,000,000 Convertible Note and the associated Warrant, which were previously reported as outstanding liabilities. This conversion directly increased the company's shareholders' equity, addressing a prior deficiency where the company failed to meet the Nasdaq minimum shareholders' equity requirement of $2.5 million as of February 24, 2025.
Outlook, Risks, and Management Commentary
Management believes the reclassification of the $9.4 million to equity satisfies the Nasdaq Shareholder Equity Rule for continued listing. However, the company is currently awaiting a formal compliance determination from the Nasdaq staff. The filing notes that the company previously submitted a compliance plan in February 2025 to regain listing status. No specific forward-looking guidance on revenue or operations is provided in this report.
Investor Verification Checklist
- Confirm the formal compliance determination from Nasdaq staff regarding the Shareholder Equity Rule.
- Verify the exact impact of the $9.4 million reclassification on the audited balance sheet as of August 25, 2025.
- Review the full text of the Securities Purchase Agreement (SPA) referenced in the December 2024 6-K for details on the warrant exercise price and conversion terms.
- Monitor for any subsequent filings regarding the company's liquidity position post-conversion.